Oxford Biomedica plc (LON:OXB)
London · Delayed Price · Currency is GBP · Price in GBX 571.00
-13.00 (-2.23%)
Jul 24, 2026, 5:12 PM GMT
Oxford Biomedica Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -31.94 | -47.27 | -188.53 | -45.98 | 19.88 |
Depreciation & Amortization | 19.85 | 22.43 | 28.71 | 26.36 | 12.46 |
Stock-Based Compensation | 4.68 | 1.69 | 3.52 | 6.47 | 3.98 |
Other Adjustments | -0.45 | 6.87 | 102.82 | -4.94 | 1.05 |
Change in Receivables | -21.66 | -33.34 | 28.79 | -17.88 | 6.89 |
Changes in Inventories | -1.85 | 2.19 | -0.25 | 0.67 | -2.61 |
Changes in Accounts Payable | 8.72 | 2.89 | -18.13 | 16.96 | -0.66 |
Changes in Accrued Expenses | -0.16 | -0.08 | 0 | - | - |
Changes in Income Taxes Payable | 5.13 | - | 7.51 | 0.56 | 0.99 |
Changes in Unearned Revenue | 18.18 | -6.05 | 7.03 | 5.16 | -16.53 |
Changes in Other Operating Activities | - | - | 0.11 | -4.09 | - |
Operating Cash Flow | 0.51 | -50.67 | -28.52 | -12.62 | 25.46 |
Operating Cash Flow Growth | - | - | - | - | 716.91% |
Capital Expenditures | -4.76 | -7.5 | -9.83 | -16.3 | -9.46 |
Sale of Property, Plant & Equipment | - | - | 8.39 | 60 | - |
Cash Acquisitions | -3.34 | 9 | - | -99.21 | - |
Other Investing Activities | 2.38 | 4.12 | - | -1.42 | - |
Investing Cash Flow | -5.72 | 5.63 | 2.81 | -56.46 | -9.46 |
Long-Term Debt Issued | 3.18 | -0.47 | - | 33.44 | - |
Long-Term Debt Repaid | -4.06 | -4.72 | -3.12 | -1.12 | -4.52 |
Net Long-Term Debt Issued (Repaid) | -0.88 | -5.19 | -3.12 | 32.32 | -4.52 |
Issuance of Common Stock | 58.06 | 17.53 | 0.65 | 77.2 | 51.6 |
Net Common Stock Issued (Repurchased) | 58.06 | 17.53 | 0.65 | 77.2 | 51.6 |
Other Financing Activities | -14.91 | -9.43 | -6.1 | -6.35 | -0.87 |
Financing Cash Flow | 42.26 | 2.91 | -12.7 | 98.62 | 46.21 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.81 | -0.94 | 0.85 | 2.8 | - |
Net Cash Flow | 37.04 | -42.13 | -38.41 | 29.55 | 62.2 |
Free Cash Flow | -4.25 | -58.16 | -38.35 | -28.91 | 15.99 |
Free Cash Flow Growth | - | - | - | - | - |
FCF Margin | -2.52% | -45.16% | -42.83% | -20.65% | 11.20% |
Free Cash Flow Per Share | -0.04 | -0.56 | -0.40 | -0.30 | 0.19 |
Levered Free Cash Flow | 14.09 | -34.49 | -145.44 | 22.48 | -1.32 |
Unlevered Free Cash Flow | 23.53 | -26.61 | -164.75 | -0.37 | 4.05 |